Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study

Detalhes bibliográficos
Autor(a) principal: Lima, Karen Rayara Bezerra
Data de Publicação: 2022
Outros Autores: Perdigão, Marcela Maria de Melo, Matos Carlos, Anna Clara Aragão, de Alencar, Manuele Carine Maciel, Nobrega, Cássia Emanuella Malta, Silva, Paulo Goberlânio de Barros
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of Health & Biological Sciences
Texto Completo: https://periodicos.unichristus.edu.br/jhbs/article/view/4340
Resumo: Objective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor.
id CHRISTUS-1_da0ce9c4d4c2cadeda5feae2aee31e20
oai_identifier_str oai:ojs.emnuvens.com.br:article/4340
network_acronym_str CHRISTUS-1
network_name_str Journal of Health & Biological Sciences
repository_id_str
spelling Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational studyVascular Access DevicesAntineoplastic AgentsComplications. Peripherally Inserted Central CatheterRisk FactorsObjective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor.UNICHRISTUS2022-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer ReviewRevisado por paresAvaliado por Paresapplication/pdfhttps://periodicos.unichristus.edu.br/jhbs/article/view/434010.12662/2317-3076jhbs.v10i1.4340.p1-7.2022Journal of Health & Biological Sciences; Vol. 10 No. 1 (2022): Journal of Health and Biological Sciences; 1-7Journal of Health and Biological Sciences; Vol. 10 Núm. 1 (2022): Journal of Health and Biological Sciences; 1-7Journal of Health & Biological Sciences; v. 10 n. 1 (2022): Journal of Health and Biological Sciences; 1-72317-30762317-308410.12662/2317-3076jhbs.v10i1.2022reponame:Journal of Health & Biological Sciencesinstname:Centro Universitário Christus (Unichristus)instacron:CHRISTUSenghttps://periodicos.unichristus.edu.br/jhbs/article/view/4340/1690Copyright (c) 2022 Journal of Health & Biological Sciencesinfo:eu-repo/semantics/openAccessLima, Karen Rayara BezerraPerdigão, Marcela Maria de MeloMatos Carlos, Anna Clara Aragãode Alencar, Manuele Carine MacielNobrega, Cássia Emanuella MaltaSilva, Paulo Goberlânio de Barros2023-09-29T20:39:16Zoai:ojs.emnuvens.com.br:article/4340Revistahttps://periodicos.unichristus.edu.br/jhbs/indexPRIhttps://periodicos.unichristus.edu.br/jhbs/oaisecretaria.jhbs@unichristus.edu.br || editor.jhbs@fchristus.edu.br2317-30762317-3084opendoar:2023-09-29T20:39:16Journal of Health & Biological Sciences - Centro Universitário Christus (Unichristus)false
dc.title.none.fl_str_mv Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
title Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
spellingShingle Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
Lima, Karen Rayara Bezerra
Vascular Access Devices
Antineoplastic Agents
Complications. Peripherally Inserted Central Catheter
Risk Factors
title_short Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
title_full Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
title_fullStr Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
title_full_unstemmed Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
title_sort Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
author Lima, Karen Rayara Bezerra
author_facet Lima, Karen Rayara Bezerra
Perdigão, Marcela Maria de Melo
Matos Carlos, Anna Clara Aragão
de Alencar, Manuele Carine Maciel
Nobrega, Cássia Emanuella Malta
Silva, Paulo Goberlânio de Barros
author_role author
author2 Perdigão, Marcela Maria de Melo
Matos Carlos, Anna Clara Aragão
de Alencar, Manuele Carine Maciel
Nobrega, Cássia Emanuella Malta
Silva, Paulo Goberlânio de Barros
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Lima, Karen Rayara Bezerra
Perdigão, Marcela Maria de Melo
Matos Carlos, Anna Clara Aragão
de Alencar, Manuele Carine Maciel
Nobrega, Cássia Emanuella Malta
Silva, Paulo Goberlânio de Barros
dc.subject.por.fl_str_mv Vascular Access Devices
Antineoplastic Agents
Complications. Peripherally Inserted Central Catheter
Risk Factors
topic Vascular Access Devices
Antineoplastic Agents
Complications. Peripherally Inserted Central Catheter
Risk Factors
description Objective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer Review
Revisado por pares
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.unichristus.edu.br/jhbs/article/view/4340
10.12662/2317-3076jhbs.v10i1.4340.p1-7.2022
url https://periodicos.unichristus.edu.br/jhbs/article/view/4340
identifier_str_mv 10.12662/2317-3076jhbs.v10i1.4340.p1-7.2022
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicos.unichristus.edu.br/jhbs/article/view/4340/1690
dc.rights.driver.fl_str_mv Copyright (c) 2022 Journal of Health & Biological Sciences
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Journal of Health & Biological Sciences
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv UNICHRISTUS
publisher.none.fl_str_mv UNICHRISTUS
dc.source.none.fl_str_mv Journal of Health & Biological Sciences; Vol. 10 No. 1 (2022): Journal of Health and Biological Sciences; 1-7
Journal of Health and Biological Sciences; Vol. 10 Núm. 1 (2022): Journal of Health and Biological Sciences; 1-7
Journal of Health & Biological Sciences; v. 10 n. 1 (2022): Journal of Health and Biological Sciences; 1-7
2317-3076
2317-3084
10.12662/2317-3076jhbs.v10i1.2022
reponame:Journal of Health & Biological Sciences
instname:Centro Universitário Christus (Unichristus)
instacron:CHRISTUS
instname_str Centro Universitário Christus (Unichristus)
instacron_str CHRISTUS
institution CHRISTUS
reponame_str Journal of Health & Biological Sciences
collection Journal of Health & Biological Sciences
repository.name.fl_str_mv Journal of Health & Biological Sciences - Centro Universitário Christus (Unichristus)
repository.mail.fl_str_mv secretaria.jhbs@unichristus.edu.br || editor.jhbs@fchristus.edu.br
_version_ 1797052854083518464